Literature DB >> 22322736

Toxicity with radiotherapy for oral cancers and its management: a practical approach.

Trinanjan Basu1, Sarbani G Laskar, Tejpal Gupta, Ashwini Budrukkar, Vedang Murthy, Jai P Agarwal.   

Abstract

Radiotherapy-induced damage in the oral mucosa is the result of the deleterious effects of radiation, not only on the oral mucosa itself but also on the skin, adjacent salivary glands, bone, dentition, and masticatory apparatus. From basic skin care to dental and oral health maintenance, several ointments and lotions, oral and parenteral medications, biological response modifiers, cytoprotective drugs, newer radiation techniques and surgery have been introduced to combat and more importantly to prevent the development of these complications. Radiotherapy-induced oral complications involve complex and dynamic pathobiological processes. This in the immediate- and long-term course lowers the quality of life and predisposes patients to serious clinical disorders. Here, we focus on these oral complications of radiotherapy, highlight preventive and therapeutic developments, and review the current treatment options available for these disorders.

Entities:  

Mesh:

Year:  2012        PMID: 22322736     DOI: 10.4103/0973-1482.92219

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  7 in total

1.  Prevention of radiation-induced bone pathology through combined pharmacologic cytoprotection and angiogenic stimulation.

Authors:  Alexis Donneys; Noah S Nelson; Joseph E Perosky; Yekaterina Polyatskaya; Jose J Rodriguez; Christian Figueredo; Cheyenne A Vasseli; Hannah C Ratliff; Sagar S Deshpande; Kenneth M Kozloff; Steven R Buchman
Journal:  Bone       Date:  2015-12-23       Impact factor: 4.398

Review 2.  Epigenetics of oral and oropharyngeal cancers.

Authors:  Daniela Russo; Francesco Merolla; Silvia Varricchio; Giovanni Salzano; Giovanni Zarrilli; Massimo Mascolo; Viviana Strazzullo; Rosa Maria Di Crescenzo; Angela Celetti; Gennaro Ilardi
Journal:  Biomed Rep       Date:  2018-07-27

3.  Mitigation of Radiation-Induced Epithelial Damage by the TLR5 Agonist Entolimod in a Mouse Model of Fractionated Head and Neck Irradiation.

Authors:  Ilia A Toshkov; Anatoli S Gleiberman; Vadim L Mett; Alan D Hutson; Anurag K Singh; Andrei V Gudkov; Lyudmila G Burdelya
Journal:  Radiat Res       Date:  2017-03-21       Impact factor: 2.841

4.  Seroprevalence of HSV-1/2 and correlation with aggravation of oral mucositis in patients with squamous cell carcinoma of the head and neck region submitted to antineoplastic treatment.

Authors:  Andreza Veruska Lira Correia; Maria Rosângela Cunha Duarte Coêlho; Georgea Gertrudes de Oliveira Mendes Cahú; Jéfferson Luis de Almeida Silva; Catarina da Mota Vasconcelos Brasil; Jurema Freire Lisboa de Castro
Journal:  Support Care Cancer       Date:  2014-12-30       Impact factor: 3.603

5.  Radiation modulates expression and related activities of c-Met protein in oral tongue squamous cell carcinoma cell lines.

Authors:  Aisha A H Al-Jamaei; Jan G A M de Visscher; Tymour Forouzanfar; Ruud H Brakenhoff; C René Leemans; Arwen Stikvoort; Behrouz Zandieh-Doulabi; Marco N Helder
Journal:  J Cancer Res Clin Oncol       Date:  2022-09-02       Impact factor: 4.322

6.  Management of radiation wounds.

Authors:  Subramania Iyer; Deepak Balasubramanian
Journal:  Indian J Plast Surg       Date:  2012-05

7.  Differential Pharmacological Activities of Oxygen Numbers on the Sulfoxide Moiety of Wasabi Compound 6-(Methylsulfinyl) Hexyl Isothiocyanate in Human Oral Cancer Cells.

Authors:  Min-Ju Lee; Wen-Ser Tseng; Jerry Cheng-Yen Lai; Hui-Ru Shieh; Chih-Wen Chi; Yu-Jen Chen
Journal:  Molecules       Date:  2018-09-21       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.